Top

International Journal of Diabetes in Developing Countries

Published in:

01-10-2018 | Review Article

Hyperglycemia and RBCs: too sweet to survive

Authors: Ahmad Mamoun Rajab, Khawaja Husnain Haider

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2018

Abstract

Sustained untreated hyperglycemia is associated with complications at molecular, cellular, and organ levels in the body that ultimately lead to comorbidities including cardiovascular-related pathologies, neuropathies, nephropathies, blindness, limb amputations, etc. Mature RBCs are unique in their structure and function; being without cellular organelles including nucleus and mitochondria, they are highly sensitive and responsive to the molecular changes in their microenvironment in general and elevated glucose in particular. They lack the ability to synthesize new proteins, replenish its enzyme-based antioxidant machinery, and replace any cellular components in the event of oxidative damage. Although they are dependent on glycolytic processing of glucose for their energy requirements, sustained exposure to hyperglycemia significantly impacts their structure as well as function and leads to early aging of the circulating RBCs with shortened lifespan. Loss of deformability due to hyperglycemia prohibits them to reversibly change their shape and squeeze through the microvasculature, a hallmark of RBC functionality for nutrient and gaseous exchanges. This mini-review of literature signifies the effect of hyperglycemia on RBCs in terms of eryptosis, lipid peroxidation in the cell membrane to compromise membrane integrity which significantly alters its deformity and coaguability, and adherence to endothelial surface leading loss of functionality and life-span.

World Health Organization. WHO global report on diabetes 2016. http://www.who.int/diabetes/global-report/.

Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88.PubMedCrossRef

Lee PG, Halter JB. The pathophysiology of hyperglycemia in older adults: clinical considerations. Diabetes Care. 2017;40(4):444–52. https://doi.org/10.2337/dc16-1732.PubMedCrossRef

Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA. 2002;288(20):2579–88. https://doi.org/10.1001/jama.288.20.2579.PubMedCrossRef

Kaneto H, Katakami N, Matsuhisa M, Matsuoka T. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm. 2010;2010:453892. 11 pagesCrossRef

Robertson RP, Harmon J, Takahasi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003;52(3):581–7. https://doi.org/10.2337/diabetes.52.3.581.PubMedCrossRef

Leney SE, Tavare JM. The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and p2otential drug targets. J Endocrinol. 2009;203(1):1–18. https://doi.org/10.1677/JOE-09-0037.PubMedCrossRef

Ebeling P, Koistinen HA, Koivisto VA. Hypothesis: Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett. 1998;436(3):301–3. https://doi.org/10.1016/S0014-5793(98)01149-1.PubMedCrossRef

Campos C. Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad Med. 2012;124(6):90–7. https://doi.org/10.3810/pgm.2012.11.2615.PubMedCrossRef

10.

Arias CF, Arias CF. How do red blood cells know when to die? R Soc Open Sci. 2017;4(4):160850. https://doi.org/10.1098/rsos.160850.PubMedPubMedCentralCrossRef

11.

Adamson JW. Regulation of red blood cell production. Am J Med. 1996;101(2):4S–6S. https://doi.org/10.1016/S0002-9343(96)00160-X.PubMedCrossRef

12.

Burrilla DR, Verneta A, Collinsa JJ, Silvera PA, Waya JC. Targeted erythropoietin selectively stimulates red blood cell expansion in vivo. PNAS. 2016;113(19):5245–50. https://doi.org/10.1073/pnas.1525388113.CrossRef

13.

Pries AR, Secomb TW, Gaehtgens P. Biophysical aspects of blood flow in the microvasculature. Cardiovasc Res. 1996;32(4):654–67. https://doi.org/10.1016/S0008-6363(96)00065-X.PubMedCrossRef

14.

Kholoussi N, Helwa I, Amara F. Red blood cells surface morphology in diabetic ketoacidosis. Middle East J Appl Sci. 2012;2(1):51–7.

15.

Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem. 1989;264(35):21340–5.PubMed

16.

Lutz HU, Bogdanova A. Mechanisms tagging senescent red blood cells for clearance in healthy humans. Front Physiol. 2013;4:387. Pages 1–15PubMedPubMedCentralCrossRef

17.

van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood. 2005;106(13):4034–42. https://doi.org/10.1182/blood-2005-04-1622.PubMedCrossRef

18.

Valentine WN, Paglia DE. The primary cause of hemolysis in enzymopathies of anaerobic glycolysis: a viewpoint. Blood Cells. 1980;6(4):819–29.PubMed

19.

Mazzanti L, Faloia E, Rabini RA, Staffolani R, Kantar A, Fiorini R, et al. Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process. Clin Biochem. 1992;25(1):41–6. https://doi.org/10.1016/0009-9120(92)80044-H.PubMedCrossRef

20.

Cohen RM, Franco RS, Joiner C. Is poor glycemic control associated with reduced red blood cell lifespan? Diabetes Care. 2004;27(4):1013–4. https://doi.org/10.2337/diacare.27.4.1013.PubMedCrossRef

21.

Huang Z, Liu Y, Mao Y, Chen W, Xiao Z, Yu Y. Relationship between glycated haemoglobin concentration and erythrocyte survival in type 2 diabetes mellitus determined by a modified carbon monoxide breath test. J Breath Res. 2017; https://doi.org/10.1088/1752-7163/aa9081.

22.

Carruthers A, DeZutter J, Ganguly A, Devaskar SU. Will the original glucose transporter isoform please stand up! Am J Physiol Endocrinol Metab. 2009;297(4):E836–48. https://doi.org/10.1152/ajpendo.00496.2009.PubMedPubMedCentralCrossRef

23.

Montel-Hagen A, Kinet S, Manel N, et al. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell. 2008;132:1039–48.PubMedCrossRef

24.

Montel-Hagen A, Blanc L, Boyer-Clavel M, Jacquet C, Vidal M, Sitbon M, et al. The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood. 2008;112:4729–38.PubMedCrossRef

25.

Vrhovac I, Breljak D, Sabolic I. Glucose transporters in the mammalian blood cells. Period Biol. 2014;116(2):131–8.

26.

Zhang J-Z, Ismail-Beigi F. Activation of GLUT1 glucose transporter in human erythrocytes. Arch Biochem Biophys. 1998;365(1):86–92.CrossRef

27.

Hajjawi OS. Glucose transport in human red blood cells. Am J Biomed Life Sci. 2013;1(3):44–52.CrossRef

28.

Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Asp Med. 2013;34(2-3):121–38. https://doi.org/10.1016/j.mam.2012.07.001.CrossRef

29.

Hu X-J, Peng F, Zhou H-Q, Zhang Z-H, Cheng W-Y, Feng H-F. The abnormality of glucose transporter in the erythrocyte membrane of Chinese type 2 diabetic patients. Biochim Biophys Acta. 2000;1466(1-2):306–14. https://doi.org/10.1016/S0005-2736(00)00175-9.PubMedCrossRef

30.

Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, et al. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem. 2005;15(5):195–202. https://doi.org/10.1159/000086406.PubMedCrossRef

31.

Fırat U, Kaya S, Çim A, Büyükbayram H, Gökalp O, Dal MS, et al. Increased caspase-3 immunoreactivity of erythrocytes in stz diabetic rats. Exp Diabetes Res. 2012;2012:316384. https://doi.org/10.1155/2012/316384.PubMedPubMedCentralCrossRef

32.

Mandal D, Mazumder A, Das P, Kundu M, Basu J. Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J Biol Chem. 2005;280(47):39460–7. https://doi.org/10.1074/jbc.M506928200.PubMedCrossRef

33.

Ghashghaeinia M, Cluitmans JCA, Akel A, Dreischer P, Toulany M, Köberle M, et al. The impact of erythrocyte age on eryptosis. Br J Haematol. 2012;157(5):606–14. https://doi.org/10.1111/j.1365-2141.2012.09100.x.PubMedCrossRef

34.

Lang E, Lang F. Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death. BioMed Res Int. 2015;2015:513518. 16 pagesPubMedPubMedCentralCrossRef

35.

Awasthi S, Gayathiri SK, Ramya R, Duraichelvan R, Dhason A, Saraswathi NT. Advanced glycation-modified human serum albumin evokes alterations in membrane and eryptosis in erythrocytes. Appl Biochem Biotechnol. 2015;177(5):1013–24. https://doi.org/10.1007/s12010-015-1793-x.PubMedCrossRef

36.

Maellaro E, Leoncini S, Moretti D, BelloItalo BD, Claudio T, De Felice C, et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. 2013;50(4):489–95. https://doi.org/10.1007/s00592-011-0274-0.PubMedCrossRef

37.

Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112(10):3939–48. https://doi.org/10.1182/blood-2008-07-161166.PubMedPubMedCentralCrossRef

38.

Himbert S, Alsop RJ, Rose M, Hertz L, Dhaliwal A, Moran-Mirabal JM, et al. The molecular structure of human red blood cell membranes from highly oriented, solid supported multi-lamellar membranes. Sci Rep. 2017;7:39661.PubMedPubMedCentralCrossRef

39.

Lieberman M, Marks A, Peet A, Chansk M. Marks’ Basic Medical Biochemistry. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 805–26.

40.

Campanella ME, Chu H, Low PS. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. PNAS. 2005;102(7):2402–7. https://doi.org/10.1073/pnas.0409741102.PubMedCrossRef

41.

Ferru E, Giger K, Pantaleo A, Campanella E, Grey J, Ritchie K, et al. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood. 2011;117(22):5998–6006. https://doi.org/10.1182/blood-2010-11-317024.PubMedPubMedCentralCrossRef

42.

Cluitmans J, Gevi F, Siciliano A, Matte A, Leal J, De Franceschi L, et al. Red blood cell homeostasis: pharmacological interventions to explore biochemical, morphological and mechanical properties. Front Mol Biosci. 2016;3:10. https://doi.org/10.3389/fmolb.2016.00010.PubMedPubMedCentralCrossRef

43.

Dzik WH. The air we breathe: three vital respiratory gases and the red blood cell: oxygen, nitric oxide, and carbon dioxide. Transfusion. 2011;51(4):676–85. https://doi.org/10.1111/j.1537-2995.2011.03114.x.PubMedCrossRef

44.

Morse EE, Kalache G, Wermino FG, Stockwell R. Increased electronic mean corpuscular volume induced by marked hyperglycemia. Ann Clin Lab Sci. 1981;11(2):184–7.PubMed

45.

Nagai R, Deemer EK, Brock JW, Thorpe SR, Baynes JW. Effect of glucose concentration on formation of AGEs in erythrocytes in vitro. Ann New York Acad Sci. 2005;1043(1):146–50. https://doi.org/10.1196/annals.1333.018.CrossRef

46.

Reshamwala S, Patil N. Biochemical changes in erythrocyte membrane in uncontrolled type 2 diabetes mellitus. Indian J Biochem Biophys. 2005;42(4):250–3.PubMed

47.

Jameson J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J, et al. Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill, Medical Publishers; 2015. p. 2423–30.

48.

Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes. 1989;38(12):1539–43. https://doi.org/10.2337/diab.38.12.1539.PubMedCrossRef

49.

Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, et al. Effect of aging on A1C levels in individuals without diabetes. Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care. 2008;31(10):1991–6. https://doi.org/10.2337/dc08-0577.PubMedPubMedCentralCrossRef

50.

Jain SK, Levinea SN, Duetta J, Hollie B. Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism. 1990;39(9):971–5. https://doi.org/10.1016/0026-0495(90)90310-9.PubMedCrossRef

51.

Viskupicova J, Blaskovic D, Galiniak S, Soszyński M, Bartosz G, Horakova L, et al. Effect of high glucose concentrations on human erythrocytes in vitro. Redox Biol. 2015;5:381–7. https://doi.org/10.1016/j.redox.2015.06.011.PubMedPubMedCentralCrossRef

52.

Dianzani M, Barrera G. Pathology and physiology of lipid peroxidation and its carbonyl products. In: Álvarez S, Evelson P, editors. Free Radical Pathophysiology. Kerala: Transworld Research Network; 2008. p. 19–38. ISBN: 978-81-7895-311-3.

53.

Blisard KS, Mieyal JJ. Characterization of the aniline hydroxylase activity of erythrocytes. J Biol Chem. 1979;254:5104–10.PubMed

54.

Starke DW, Blisard KS, Mieyal JJ. Substrate specificity of the monooxygenase activity of hemoglobin. Mol Pharrnacol. 1984;25:467–75.

55.

Edwards CJ, Fuller J. Oxidative stress in erythrocytes. Comp Haematol Int. 1996;6(1):24–31. https://doi.org/10.1007/BF00368098.CrossRef

56.

Mohanty JG, Nagababu E, Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol. 2014;5:84.PubMedPubMedCentralCrossRef

57.

Pandey KB, Rizvi SI. Biomarkers of oxidative stress in red blood cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):131–6. https://doi.org/10.5507/bp.2011.027.PubMedCrossRef

58.

Varashree BS, Bhat GP. Correlation of lipid peroxidation with glycated hemoglobin levels in diabetes mellitus. Online J Health Allied Sci. 2011;10(2):11.

59.

Jain SK, Mohandas N, Clark M, Shohet SB. The effect of malonyldialdehyde, a product of lipid peroxidation, on the deformability, dehydration, and 51-Cr-survival of erythrocytes. Br J Haematol. 1983;53(2):247–55. https://doi.org/10.1111/j.1365-2141.1983.tb02018.x.PubMedCrossRef

60.

Rodrigo R, Bächler JP, Araya J, Prat H, Passalacqua W. Relationship between (Na+K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects. Mol Cell Biochem. 2007;303(1-2):73–81. https://doi.org/10.1007/s11010-007-9457-y.PubMedCrossRef

61.

Cazzola R, Rondanelli M, Russo-Volpe S, Ferrari E, Cestaro B. Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res. 2004;45(10):1846–51. https://doi.org/10.1194/jlr.M300509-JLR200.PubMedCrossRef

62.

Bravi MC, Armiento A, Laurenti O, Cassone-Faldetta M, De Luca O, Moretti A, et al. Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism. 2006;55(5):691–5. https://doi.org/10.1016/j.metabol.2006.01.003.PubMedCrossRef

63.

Sompong W, Cheng H, Adisakwattana S. Protective effects of ferulic acid on high glucose-induced protein glycation, lipid peroxidation, and membrane ion pump activity in human erythrocytes. PLoS One. 2015;10(6):e0129495. https://doi.org/10.1371/journal.pone.0129495.PubMedPubMedCentralCrossRef

64.

Iannello S, Milazzo P, Belfiore F. Animal and human tissue Na, K-ATPase in obesity and diabetes: a new proposed enzyme regulation. Am J Med Sci. 2007;333:1–9.PubMedCrossRef

65.

Srivatsan R, Das S, Gadde R, Manoj-Kumar K, Taduri S, Rao N. Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med. 2009;12:121–7.PubMed

66.

Nans A, Mohandas N, Stokes DL. Native ultrastructure of the red cell cytoskeleton by cryo-electron tomography. Biophys J. 2011;101(10):2341–50. https://doi.org/10.1016/j.bpj.2011.09.050.PubMedPubMedCentralCrossRef

67.

Li J, Lykotrafit G, Dao M, Suresh S. Cytoskeletal dynamics of human erythrocyte. PNAS. 2007;104(12):4937–42. https://doi.org/10.1073/pnas.0700257104.PubMedCrossRef

68.

Simmons D. Increased red cell count in diabetes and pre-diabetes. Diabetes Res Clin Pract. 2010;90(3):e50–3. https://doi.org/10.1016/j.diabres.2010.07.005.PubMedCrossRef

69.

Babu N, Singh M. Influence of hyperglycemia on aggregation, deformability and shape parameters of erythrocytes. Clin Hemorheol Microcirc. 2004;31:273–80.PubMed

70.

van Buys A, van Rooy M-J, Soma P, Papendorp DV, Lipinski B, Pretorius E. Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc Diabetol. 2013;12(1):25. https://doi.org/10.1186/1475-2840-12-25.PubMedPubMedCentralCrossRef

71.

Agrawal R, Smart T, Nobre-Cardoso J, Richards C, Bhatnagar R, Tufail A, et al. Assessment of red blood cell deformability in type 2 diabetes mellitus and diabetic retinopathy by dual optical tweezers stretching technique. Sci Rep. 2016;6(1):15873.PubMedPubMedCentralCrossRef

72.

Elshennawy ATM. Effect of gestational diabetes on gross morphology, histology and histochemistry of human placenta. Endocrinol Metab Syndr. 2016;5:1.

73.

Kamana KC, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(suppl 2):14–20.

74.

Gioia S, Cerekja A, Larciprete G, Vallone C, Demaliaj E, Evangelista MT, et al. Gestational diabetes: is it linked to platelets hyperactivity? Platelets. 2009;20(2):140–1. https://doi.org/10.1080/09537100802630062.PubMedCrossRef

75.

Min Y, Ghebremeskel K, Lowy C, Thomas B, Crawford MA. Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes. Diabetologia. 2004;47(1):75–81. https://doi.org/10.1007/s00125-003-1275-5.PubMedCrossRef

76.

Min Y, Nam J-H, Ghebremeskel K, Kim A, Crawford M. A distinctive fatty acid profile in circulating lipids of Korean gestational diabetics: a pilot study. Diabetes Res Clin Pract. 2006;73(2):178–83. https://doi.org/10.1016/j.diabres.2006.01.003.PubMedCrossRef

77.

Taschereau-Charron A, Da Silva MS, Bilodeau J-F, Morisset A-S, Julien P, Rudkowska I. Alterations of fatty acid profiles in gestational diabetes and influence of the diet. Maturitas. 2017;99:98–104. https://doi.org/10.1016/j.maturitas.2017.01.014.PubMedCrossRef

78.

Moretti N, Rabini RA, Nanetti L, Grechi G, Curzi MC, Cester N, et al. Sialic acid content in erythrocyte membranes from pregnant women affected by gestational diabetes. Metabolism. 2002;51(5):605–8. https://doi.org/10.1053/meta.2002.32015.PubMedCrossRef

Title: Hyperglycemia and RBCs: too sweet to survive
Authors: Ahmad Mamoun Rajab
Khawaja Husnain Haider
Publication date: 01-10-2018
Publisher: Springer India
Published in: International Journal of Diabetes in Developing Countries / Issue 4/2018
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-018-0613-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Metabolomics study on the association between nicotinamide N-methyltransferase gene polymorphisms and type 2 diabetes

Sleep and diabetes and the kidney

Biomarkers of renal dysfunction among Ghanaian patients with type 2 diabetes mellitus- a cross-sectional study

Comparison of effectiveness of premixed insulin with long-acting insulin in diabetes: evidence from real-world cohort studies—systematic review and meta-analyses

ADIPOR2 variant is associated with higher fasting glucose level in non-diabetic Chinese Han population

Effect of telemedicine messages integrated with peer group support on glycemic control in type 2 diabetics, Kingdom of Saudi Arabia

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials